The new officer, bringing more than 15 years of experience in diagnostics and data science to the association, will lead scientific strategy and partnerships.
The Association for Diagnostics & Laboratory Medicine (ADLM) has named H Timothy Hsiao, PhD, CSAP, as its chief scientific officer, effective July 21.
In this role, Hsiao will join the executive leadership team to guide the association’s scientific strategy, programs, and partnerships. He will work with volunteer leaders, members, and staff to strengthen the association’s scientific agenda, expand education in emerging areas of laboratory medicine, and apply advances in diagnostics and data science to clinical practice.
“Dr Hsiao brings the scientific depth and strategic experience ADLM needs at a time when data science and new diagnostic technologies are reshaping laboratory medicine,” says Melanie J Wells, CEO of ADLM, in a release. “His experience building partnerships across government, academia, industry, and the nonprofit sector will help ADLM strengthen the role of laboratory medicine professionals and advance the science that improves clinical decision-making and patient care.”
Hsiao has more than 15 years of experience leading scientific programs across the federal government, nonprofit sector, and scientific societies. Most recently, he served as principal advisor and senior innovation strategy and management advisor for the Advanced Research Projects Agency for Health. In that capacity, he advised on the development of national innovation programs and evaluated emerging technologies in advanced diagnostics and data science, including microfluidic liquid biopsy, quantum sensing, multimodal data integration, artificial intelligence, and quantum computing.
Previously, Hsiao served as chief scientific officer and head of research strategy and alliances at the Solve ME/CFS Initiative, where he led scientific strategy for precision medicine, diagnostics, and clinical research. He also held the role of director of the department of scientific affairs at the American Society for Radiation Oncology and served as a program director at the National Institutes of Health. At the National Center for Advancing Translational Sciences, he managed approximately $50 million in federal investments for clinical and translational research infrastructure and workforce development.
Hsiao earned a PhD in molecular biophysics and biochemistry from Yale University, an MSc in biochemical research from Imperial College London, and a BSc from National Chung-Hsing University.
“ADLM’s members are central to the future of healthcare because they generate the evidence, insight, and expertise that clinicians and patients rely on every day,” says Hsiao in a release. “I am honored to join ADLM and look forward to working with its members, volunteer leaders, and staff to advance scientific programs that connect laboratory innovation with real-world impact for patients and the public.”
